MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY

MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY

In total, 60 45-70-year-old patients with Functional Class II-III chronic heart failure (CHF) after a myocardial infarction, compensated or sub-compensated Type 2 diabetes mellitus (DM-2), and autonomous cardiac neuropathy were examined. The basis therapy included enalapril, bisoprolol, aspirin, and...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. E. Statsenko, S. V. Turkina, S. V. Belenkova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2009-06-01
Series:	Российский кардиологический журнал
Subjects:	chronic heart failure type 2 diabetes mellitus autonomous cardiac neuropathy mildronate
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1357
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECTS OF MILDRONATE, AS A PART OF COMBINED HEART FAILURE THERAPY, ON CARBOHYDRATE AND LIPID METABOLISM AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2010-04-01)

DIAGNOSTIC VALUE OF SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN CARDIAC AUTONOMIC NEUROPATHY AND TYPE 2 DIABETES MELLITUS
by: E. Yu. Lunina, et al.
Published: (2012-06-01)

Endothelial dysfunction in heart failure with normal systolic function, and its correction with a metabolic agent, mildronate
by: V. P. Geychenko, et al.
Published: (2005-08-01)

MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY
by: L. G. Voronkov, et al.
Published: (2016-01-01)

MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: M. E. Statsenko, et al.
Published: (2011-08-01)

Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
by: E. Yu. Lunina, et al.
Published: (1970-01-01)

Mildronate effects on cognitive function in elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2012-10-01)

EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CIRCADIAN RHYTHM OF HEART RATE VARIABILITY PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2018-06-01)

Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
by: V. A. Serhiyenko, et al.
Published: (2019-05-01)

MILDRONATE POTENTIAL FOR CARDIAC ARRHYTHMIA PREVENTION IN PERIOPERATIVE PERIODcardiac arrhythmias, ischemia, metabolic disturbances, cytoprotectors, antioxidants, operation-related stress, general anesthesia, Mildronate
by: V. P. Mikhin, et al.
Published: (2014-02-01)

Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
by: V. P. Mikhin, et al.
Published: (2012-02-01)

Correlation between arterial wall stiffness, N-terminal prohormone of brain natriuretic peptide, functional and structural myocardial abnormalities in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
by: Viktoriya Alexandrovna Serhiyenko, et al.
Published: (2013-12-01)

Intensive Glycemic Treatment Mitigates Cardiovascular and Mortality Risk Associated With Cardiac Autonomic Neuropathy in Type 2 Diabetes
by: Huimin Zhou, et al.
Published: (2025-05-01)

Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes
by: Renata Risi, et al.
Published: (2025-02-01)

Assessing the impact of supervised interval training on cardiovascular autonomic neuropathy in type 2 diabetes patients
by: Laura Stirane, et al.
Published: (2025-08-01)

Clinical characteristics of gastroesophageal reflux disease in adolescents with diabetic cardiac autonomic neuropathy
by: Sergey Evgen'evich Kostyakov, et al.
Published: (2014-12-01)

Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross‐Sectional Study
by: Ruixue Feng, et al.
Published: (2025-07-01)

The initial level of heart rate variability determines the dynamics of the neuropathy of the autonomic nervous system and temperature sensitivity in rats with streptozotocin diabetes
by: Maria P. Morozova, et al.
Published: (2019-08-01)

DISORDERS OF THE AUTONOMIC NERVOUS SYSTEM IN THE CARDIOLOGY PRACTICE: FOCUS ON THE ANALYSIS OF HEART RATE VARIABILITY
by: E. B. Akhmedova, et al.
Published: (2015-09-01)

INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

Sex Differences in the Association Between Cardiovascular Autonomic Neuropathy and Mortality in Patients With Type 2 Diabetes: The ACCORD Study
by: Ziwei Zhou, et al.
Published: (2025-01-01)

Coherence Analysis of Cardiovascular Signals for Detecting Early Diabetic Cardiac Autonomic Neuropathy: Insights into Glycemic Control
by: Yu-Chen Chen, et al.
Published: (2025-06-01)

NEW POTENTIAL OF PHARMACEUTICAL CORRECTION OF CARDIAC AUTONOMIC NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE
by: M. E. Statsenko, et al.
Published: (2011-10-01)

THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

The Impact of Diabetic Polyneuropathy and Autonomic Neuropathy on the Risk of Ischemic Stroke
by: Selin Betaş Akın, et al.
Published: (2025-04-01)

Mildronate effectiveness in post-hospital rehabilitation of patients with myocardial infarction
by: V. P. Mikhin, et al.
Published: (2012-04-01)

Diabetic distress, low-grade chronic inflammation, and cardiac autonomic neuropathy in internally displaced people (literature review and own observations)
by: V.A. Serhiyenkо
Published: (2025-06-01)

ДИАБЕТИЧЕСКАЯ АВТОНОМНАЯ КАРД ИАЛЬНАЯ НЕЙРОПАТИЯ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА: ФОКУС НА НЕРЕШЁННЫЕ ПРОБЛЕМЫ
by: М. Е. Стаценко, et al.
Published: (2013-06-01)

CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-04-01)

ANTIOXIDANT EFFECT OF MILDRONATE IN PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-02-01)

Severe neuropathy in a patient with ischemic heart disease and type 2 diabetes
by: Victor Yur'evich Kalashnikov, et al.
Published: (2016-11-01)

Impairment of microvascular blood flow in patients with type 2 diabetes and cardiovascular autonomic neuropathy
by: T. A. Zelenina, et al.
Published: (2021-02-01)

Features of short-term heart rate variability in internally displaced people with type 2 diabetes mellitus
by: V.A. Serhiyenko, et al.
Published: (2025-05-01)

MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01)

Features of Lipid Spectrum and Insulin Resistance Parameters in Patients with Type 2 Diabetes Mellitus and Cardiac Autonomic Neuropathy and Appropriateness of Simvastatin and Omega-3 Polyunsaturated Fatty Acids Combined Prescription
by: Azhmi S., et al.
Published: (2017-09-01)

Risk factors for diabetic autonomic cardiovascular neuropathy in children and adolescents with type 1 diabetes mellitus
by: Maria Rustemovna Shaidullina, et al.
Published: (2013-09-01)

The effect of α-lipoic acid treatment on plasma asymmetric dimethylarginine, a biomarker of endothelial dysfunction in diabetic neuropathy
by: Ferenc Sztanek, et al.
Published: (2020-12-01)

Prediction of cardiac autonomic dysfunction using heart rate response to deep breathing test among type 2 diabetes mellitus
by: Sohini Raje, et al.
Published: (2025-04-01)

EXERCISE CAPACITY IN PATIENTS WITH CORONARY HEART DISEASE AND PERIPHERAL ARTERY DISEASE, RECEIVING LONG-TERM MILDRONATE THERAPY
by: V. Ya. Dzerve, et al.
Published: (2011-02-01)

PHARMACOTHERAPY POSSIBILITIES OF CARDIOVASCULAR AUTONOMOUS NEUROPATHY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS AT THE PRECLINICAL STAGE
by: N. V. Malyuzhinskaya, et al.
Published: (2022-03-01)